Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Lavi

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Leukemia Research|August 27, 2017
Ruxolitinib for the management of myelofibrosis: Results of an international physician surveyMartin H Ellis, Maya Koren-Michowitz, Noa Lavi, et al.
Bone Marrow Research|December 18, 2012
New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomibNetanel Horowitz, Ilana Oren, Noa Lavi, et al.
Infection|January 22, 2016
Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcomeEmilia Hardak, Irit Avivi, Lina Berkun, et al.
The Israel Medical Association Journal : IMAJ|May 5, 2017
Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell LymphomaNoa Lavi, Gali Shapira, Ariel Zilberlicht, et al.
American Journal of Obstetrics & Gynecology MFM|November 18, 2022
Assessment of labor progress by ultrasound vs manual examination: a randomized controlled trialMaya Oberman, Inbal Avrahami, Noa Lavi Shoseyov, et al.
Pathology, Research and Practice|September 20, 2020
Multicentric Castleman disease presenting as a chylous pleural effusionDanny Epstein, Yaniv Zohar, David Ovadya, et al.
Carcinogenesis|August 14, 2018
Semaphorin-3A inhibits multiple myeloma progression in a mouse modelNoa Lavi, Ofra Kessler, Keren Ziv, et al.
Acta Haematologica|October 2, 2024
Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the LiteratureEyal Lebel, Vladimir Vainstein, Paolo Milani, et al.
Frontiers in Oncology|June 3, 2024
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myelomaDarrell White, Gary J Schiller, Sumit Madan, et al.
Acta Haematologica|December 14, 2020
Management and Outcome of Venous Thrombosis in Patients with Myeloproliferative Neoplasms: Data from the Israeli MPN Working GroupOdit Gutwein, Noa Lavi, Merav Barzilai, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Leukemia Research|August 27, 2017
Ruxolitinib for the management of myelofibrosis: Results of an international physician surveyMartin H Ellis, Maya Koren-Michowitz, Noa Lavi, et al.
Bone Marrow Research|December 18, 2012
New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomibNetanel Horowitz, Ilana Oren, Noa Lavi, et al.
Infection|January 22, 2016
Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcomeEmilia Hardak, Irit Avivi, Lina Berkun, et al.
The Israel Medical Association Journal : IMAJ|May 5, 2017
Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell LymphomaNoa Lavi, Gali Shapira, Ariel Zilberlicht, et al.
American Journal of Obstetrics & Gynecology MFM|November 18, 2022
Assessment of labor progress by ultrasound vs manual examination: a randomized controlled trialMaya Oberman, Inbal Avrahami, Noa Lavi Shoseyov, et al.
Pathology, Research and Practice|September 20, 2020
Multicentric Castleman disease presenting as a chylous pleural effusionDanny Epstein, Yaniv Zohar, David Ovadya, et al.
Carcinogenesis|August 14, 2018
Semaphorin-3A inhibits multiple myeloma progression in a mouse modelNoa Lavi, Ofra Kessler, Keren Ziv, et al.
Acta Haematologica|October 2, 2024
Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the LiteratureEyal Lebel, Vladimir Vainstein, Paolo Milani, et al.
Frontiers in Oncology|June 3, 2024
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myelomaDarrell White, Gary J Schiller, Sumit Madan, et al.
Acta Haematologica|December 14, 2020
Management and Outcome of Venous Thrombosis in Patients with Myeloproliferative Neoplasms: Data from the Israeli MPN Working GroupOdit Gutwein, Noa Lavi, Merav Barzilai, et al.
Pageof 6